| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2123823 | European Journal of Cancer | 2010 | 6 Pages |
Abstract
FDG PET/CT detected extra-axillary lymph node involvement in almost one-third of the patients with stage II-III breast cancer, including regions not evaluable with ultrasound. FDG PET/CT may be useful as an additional imaging tool to assess extra-axillary lymph node metastasis, with an impact on the adjuvant radiotherapy management.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Tjeerd S. Aukema, Marieke E. Straver, Marie-Jeanne T.F.D. Vrancken Peeters, Nicola S. Russell, Kenneth G.A. Gilhuijs, Wouter V. Vogel, Emiel J.T. Rutgers, Renato A. Valdés Olmos,